When evaluating treatment strategies for a 14-year-old patient with obsessive-compulsive disorder (OCD), the PMHNP considers that evidence-based data from the Pediatric OCD Treatment Study (POTS) suggests that best outcomes are achieved with cognitive behavioral therapy (CBT) and:A.Clomipramine (Anafranil)B.Sertraline (Zoloft)C.Aripiprazole (Abilify)D.Lithium (Eskalith).